Diabetes & Life Expectancy Calculator | How Diabetes Affects How Long You Live

The Average Years Lost — By Type and Control

Rawshani et al. (2017) analysed over 700,000 patients in the Swedish National Diabetes Register and found that, compared to matched non-diabetic controls, Type 2 diabetes reduces life expectancy by an average of 6 years and Type 1 by approximately 11–13 years. Crucially, these averages mask enormous variation driven by one number: HbA1c.

HbA1c Is the Adjustable Parameter

The UK Prospective Diabetes Study (UKPDS), which followed 5,102 newly diagnosed T2D patients for up to 20 years, found that each 1% reduction in HbA1c was associated with a 21% reduction in diabetes-related deaths, a 14% reduction in heart attacks, and a 37% reduction in microvascular complications.

This is the most powerful finding in the diabetes-mortality literature: the relationship is continuous. There is no threshold below which further improvement stops helping. Moving from an HbA1c of 9.5% to 8.5% is as proportionally valuable as moving from 8.5% to 7.5%.

• 1% drop in HbA1c: 21% fewer diabetes-related deaths (UKPDS)
• 1% drop in HbA1c: 14% fewer myocardial infarctions (UKPDS)
• 1% drop in HbA1c: 37% fewer microvascular events (UKPDS)
• HbA1c < 7.0% vs ≥ 9.0%: Mortality HR ~0.56, 44% lower risk (Tancredi et al. 2015, NEJM)

The Canadian Picture

According to the Public Health Agency of Canada (PHAC), 11.7% of Canadians aged 20 and older — roughly 3.4 million people — live with diagnosed diabetes as of 2020. Type 2 diabetes accounts for approximately 90–95% of all cases.

The Canadian Institute for Health Information (CIHI) estimates that diabetes costs the Canadian health system approximately $3.8 billion per year in direct costs, driven primarily by cardiovascular complications.

Regional variation is significant: First Nations communities experience diabetes prevalence rates 3–5× the national average (PHAC, 2019), and provinces with higher rates of obesity and sedentary activity — particularly in Atlantic Canada — show higher rates of poorly controlled T2D.

What Actually Moves the Needle

• Blood Sugar Control (HbA1c): The primary lever. Sustained HbA1c below 7.0% reduces all-cause mortality by up to 44% compared to HbA1c above 9.0% (Tancredi et al., 2015). Every 1% reduction matters continuously — there is no plateau.
• Aerobic Fitness (VO2 Max): Cardiorespiratory fitness is independently protective even with diabetes. Kokkinos et al. (2022) found that fit diabetic individuals had lower mortality than unfit non-diabetic individuals.
• Blood Pressure & LDL Control: UKPDS showed that tight blood pressure control (target <150/85 mmHg) reduced diabetes-related deaths by 32% and strokes by 44%.
• Smoking Cessation: A diabetic smoker faces approximately 2.5× the mortality risk of a non-smoking diabetic (WHO, 2016). Quitting is the single fastest way to reduce hazard.
• Weight & Remission: The DiRECT trial (2019, The Lancet) showed that intensive dietary management achieving >15 kg weight loss can induce T2D remission in ~36% of patients at 2 years.

Related Calculators

• Blood Pressure & Life Expectancy Calculator
• VO2 Max Longevity Calculator
• Healthspan Calculator

Frequently Asked Questions

Sources

• Rawshani et al. (2017). Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes. NEJM.
• Tancredi et al. (2015). Excess Mortality among Persons with Type 2 Diabetes. NEJM.
• UK Prospective Diabetes Study (UKPDS) Group (1998). The Lancet.
• Gregg et al. (2012). Changes in Diabetes-Related Complications in the United States. NEJM.
• Public Health Agency of Canada (2020). Diabetes in Canada.
• Statistics Canada (2023). Life Tables, Canada, Provinces and Territories, 2020 to 2022.